Director Ratajczak buys 5,000 shares of CRWS at $2.70; 3 rapid purchases in 7 days amid stock down 41.4% from high
Donald R Ratajczak, a director, purchased 5,000 shares at $2.70 on 2025-11-19, increasing his holdings to 336,181 shares. This is the third discretionary buy in a one-week window (after purchases on 2025-11-17 and 2025-11-14), a pattern of continuous accumulation. The stock is trading 41.4% below its 52-week high of $4.66 and down 5.2% over 30 days and 9.4% over 90 days. While Ratajczak's cross-ticker track record shows strong performance (17 prior buys with a 90-day win rate of 92.86%), his prior trades at CRWS are mixed: his August 2024 buy showed a 90-day return of -3.6%, and only 1 of 2 measurable prior CRWS purchases was well-timed at the 90-day mark. The company posted revenue of $23.7M in the latest quarter and net income of $1.2M, but was unprofitable over its most recent full fiscal year, creating underlying business uncertainty that adds context to the recent accumulation pattern.
Director buys 30,000 shares across 3 trades (Nov 13-17) at blended $2.74, raising stake 10.0% to 331.2K shares
Director Ratajczak executed 3 separate open-market purchases totaling 30,000 shares for $82,350.00 over a tight 4-day window (2025-11-13 to 2025-11-17) at prices ranging from $2.69 to $2.80, with a blended average price of $2.74. His stake grew 10.0% from 301.2K to 331.2K shares in a single filing. His prior trades at CRWS show a 90-day pattern that was well-timed in 4 of 5 cases, though his most recent CRWS buy (2024-08-16) posted only +0.2% return over 30 days and modest subsequent performance. The current stock price of $2.73 is -41.4% from the 52-week high of $4.66 and has declined -4.0% over 30 days and -8.1% over 90 days, suggesting this purchase occurs in a period of sustained downward pressure. Fundamentally, the company posted $23.7M in quarterly revenue with $1.2M net income in the latest quarter, but reported negative full-year net income in the most recent fiscal year, indicating operational challenges that may warrant monitoring alongside this director-level accumulation.
Director Ratajczak buys 10,661 shares of CRWS at $4.71; stock down 21.7% from 52-week high but insider holds 261,164 shares post-trade.
Director Donald R. Ratajczak purchased 10,661 shares at $4.71, increasing his holdings to 261,164 shares—a 4.3% addition to his existing position. This buy occurs while the stock trades at $4.62, down 21.7% from its 52-week high of $5.90 and down 4.9% over the prior 30 days, placing the purchase near depressed recent levels. Notably, Ratajczak has demonstrated a strong track record at CRWS specifically: his 5 prior purchases at this ticker over late December 2023 were all followed by positive 90-day returns (ranging from +7.8% to +16.4%), indicating consistent buy-timing at this company. The company's fundamentals show annual revenue growth of +16.8% and a P/E of 11.27, though the latest quarter posted a net loss of $322,000 on $16.2M revenue. The continued accumulation by a director who has successfully timed purchases at this specific ticker in the past warrants observation of whether this pattern repeats.
